These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4394192)

  • 21. [Pentaerythritol "forte" in the treatment of coronary disease (author's transl)].
    Kawecka-Jaszcz K; Kocemba J; Moczurad K; Wójcikiewiczowa O
    Przegl Lek; 1978; 35(8):675-8. PubMed ID: 715249
    [No Abstract]   [Full Text] [Related]  

  • 22. [Physio-pharmacology of coronary insufficiency. I].
    Campese VM; Marino A
    Clin Ter; 1974 Mar; 69(4):301-20. PubMed ID: 4152441
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical evaluation of the therapeutic action of a beta-blocking agent associated with a nitroderivative].
    Salmini G; Cione R; Oldrini R
    Minerva Cardioangiol; 1970 May; 18(5):311-5. PubMed ID: 5515015
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experiences with a combined glycoside-nitrite treatment in chronic coronary insufficiency].
    Wick T
    Med Welt; 1969 Oct; 42():2327-30. PubMed ID: 5355678
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic effects of pentaerythritol tetranitrate in the immediate postmyocardial-infarction period.
    Mellen HS; Goldberg HS; Friedman HF
    N Engl J Med; 1967 Feb; 276(6):319-22. PubMed ID: 6016292
    [No Abstract]   [Full Text] [Related]  

  • 26. New dimension in angina pectoris therapy.
    Russek HI
    Geriatrics; 1969 Mar; 24(3):81-95. PubMed ID: 4885554
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of coronary insufficiency with a combination of 2 nitro-derivatives. Controlled pluricentric clinical trial].
    Di Prisco AU; Vaccari GL; Soro A; Mora A
    Minerva Med; 1975 Feb; 66(12):551-61. PubMed ID: 1113905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Ambulatory therapy regimen in patients following myocardial infarct in relation to echocardiography and the stress test].
    Schaller K; Ziske U
    Z Gesamte Inn Med; 1989 Sep; 44(18):543-5. PubMed ID: 2573978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study on therapeutic efficacy of 2-benzofuryl-p-chlorophenyl carbinol (Clobenfurol) alone or in association with pentaerythritol tetranitrate].
    Martinelli M; Villecco A
    Minerva Cardioangiol; 1973 Jan; 21(1):60-6. PubMed ID: 4572004
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 31. [Value of combination therapy of pentalong (PETN) with obsidan (propranolol) in patients with coronary insufficiency].
    Gruber G; Hambsch K
    Z Arztl Fortbild (Jena); 1977 Feb; 71(4):167-71. PubMed ID: 868090
    [No Abstract]   [Full Text] [Related]  

  • 32. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

  • 33. [Combined treatment of chronic coronary disease with pentaerythritol tetranitrate and propranolol].
    Florkiewicz H; Rymar B; Markiewicz M; Trojnar R; Rumiński W
    Pol Tyg Lek; 1981 Apr; 36(14):501-3. PubMed ID: 7267422
    [No Abstract]   [Full Text] [Related]  

  • 34. [The combination preparation VisanoCor in patients with angina pectoris with special monitoring of urinary catecholamines].
    Hagel H
    Fortschr Med; 1981 Nov; 99(41):1714-7. PubMed ID: 7319440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differential treatment of coronary heart disease].
    Weser C; Scheidler K
    Z Arztl Fortbild (Jena); 1974 Jul; 68(13):647-53. PubMed ID: 4216180
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the clinical use of a new drug in the therapy of coronary insufficiency].
    Bracchetti D; Spada E
    G Clin Med; 1966 Dec; 47(12):1261-82. PubMed ID: 4173047
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new beta blocking agent: LB-46. Clinical use in the treatment of rhythm disorders and coronary insufficiency].
    Dutoit A; Lepoutre B; Leuridan B; Croccel L; Giard P
    J Sci Med Lille; 1972 Feb; 90(2):83-9. PubMed ID: 4403207
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the objective evaluation of the effects of coronary vasoactive drugs].
    Lenti G; Cherchi A; Raffo M; Porrazzo G
    Minerva Med; 1966 Feb; 57(12):455-9. PubMed ID: 5910815
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of beta adrenergic blockaders on the effort test in coronary insufficiency].
    Demiroglu C; Oztürk M
    Presse Med (1893); 1971 Apr; 79(17):765-6. PubMed ID: 4396515
    [No Abstract]   [Full Text] [Related]  

  • 40. [The drug therapy effect on functional and organic stenocardias].
    Gill E
    Med Klin; 1966 Aug; 61(32):1258-60. PubMed ID: 4870033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.